Skip to main content

Cook IVC Filter Bellwether Trial Update

Cook IVC Filter Bellwether Trial Update

Cook IVC Filter Bellwether Trial Update

Introduction

Georgia resident's trial over defective Cook Celect Cava Filter is scheduled to begin on January 14, 2019, in the U.S. District of Arizona. In the complaint filed, the plaintiff stated that the filter broke and migrated to other parts in her body piercing her thigh. Ultimately, she got it removed surgically, but a part of the filter still remained embedded in her spine.

Cook Medical Inc. has been allowed to present testimony from a psychiatrist at the upcoming trial who disagrees with the allegations from the woman that the company's blood-clot filter caused her severe pain and emotional distress. On the other hand, U.S. District Judge Richard Young overseeing the federal litigation denied the company's plea to depose two doctors who acted as paid consultants to the plaintiff's expert scheduled to testify in the upcoming bellwether trial. The company filed a motion last week arguing that the plaintiff was unable to prove Cook's post-sale failure to warn conduct caused her injuries.

On May 24, 2018, a Texas jury ordered Cook Medical to pay  $1.2 million to a plaintiff for serious injuries he suffered from the Cook Celect filter and for failure to warn about its hazards. Several Cook IVC filter lawsuits are centralized since October 2014 under MDL No. 2570 (IN RE: Cook Medical, Inc., IVC Filters Marketing, Sales Practices, and Products Liability Litigation), in the Southern District of Indiana.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!